Advanced search
Publication Cover
OncoImmunology Volume 12, 2023 - Issue 1
Submit an article Journal homepage
1,395
Views
0
CrossRef citations to date
0
Altmetric
Brief report

Enhancing T cell anti-tumor efficacy with a PD1-TIGIT chimeric immune-checkpoint switch receptor

Jingjing Zhaoa Department of Cell Biology and MOE Engineering Research Center of Regenerative Medicine, School of Basic Medical Sciences, State Key Laboratory of Natural and Biomimetic Drugs, Peking University Health Science Center, Peking University, Hadian District, Beijing, ChinaView further author information
,
Jiebin Donga Department of Cell Biology and MOE Engineering Research Center of Regenerative Medicine, School of Basic Medical Sciences, State Key Laboratory of Natural and Biomimetic Drugs, Peking University Health Science Center, Peking University, Hadian District, Beijing, ChinaView further author information
,
Changwen Dengb Department of Respiratory and Critical Care Medicine, Shanghai East Hospital, School of medicine, Tongji University, Shanghai, ChinaView further author information
,
Qianjing Zhanga Department of Cell Biology and MOE Engineering Research Center of Regenerative Medicine, School of Basic Medical Sciences, State Key Laboratory of Natural and Biomimetic Drugs, Peking University Health Science Center, Peking University, Hadian District, Beijing, ChinaView further author information
,
Shicheng Suna Department of Cell Biology and MOE Engineering Research Center of Regenerative Medicine, School of Basic Medical Sciences, State Key Laboratory of Natural and Biomimetic Drugs, Peking University Health Science Center, Peking University, Hadian District, Beijing, ChinaView further author information
,
Honggang Lia Department of Cell Biology and MOE Engineering Research Center of Regenerative Medicine, School of Basic Medical Sciences, State Key Laboratory of Natural and Biomimetic Drugs, Peking University Health Science Center, Peking University, Hadian District, Beijing, ChinaView further author information
,
Yun Baia Department of Cell Biology and MOE Engineering Research Center of Regenerative Medicine, School of Basic Medical Sciences, State Key Laboratory of Natural and Biomimetic Drugs, Peking University Health Science Center, Peking University, Hadian District, Beijing, ChinaCorrespondence[email protected]
View further author information
&
Hongkui Denga Department of Cell Biology and MOE Engineering Research Center of Regenerative Medicine, School of Basic Medical Sciences, State Key Laboratory of Natural and Biomimetic Drugs, Peking University Health Science Center, Peking University, Hadian District, Beijing, China;c College of Life Sciences, Peking-Tsinghua Center for Life Sciences, Peking University, Beijing, ChinaCorrespondence[email protected]
View further author information
 show all
Article: 2265703 | Received 06 Jun 2023, Accepted 28 Sep 2023, Published online: 05 Oct 2023

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.